| Spirig HealthCare AG - Bosutinib Spirig HC 400 mg, Filmtabletten | | 69464 | | 02 | | Bosutinib Spirig HC 400 mg | | Filmtabletten | | L01EA04 | | Bosutinib | | 22.01.2025 | | |
| | Composition | | bosutinibum 400 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 4000, talcum, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 1.62 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Bosutinibum | 400 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 4000 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 28 | DDP | DDP | A | | Non |
|
|
